Kidney disease and reproductive health
GBD Chronic Kidney Disease Collaboration. Global, regional, and national burden of chronic kidney disease, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet. 395, 709–733 (2020).
Dumanski, S. M. & Ahmed, S. B. Fertility and reproductive care in chronic kidney disease. J. Nephrol. 32, 39–50 (2019).
Google Scholar
Mills, K. T. et al. A systematic analysis of worldwide population-based data on the global burden of chronic kidney disease in 2010. Kidney Int. 88, 950–957 (2015).
Google Scholar
Feig, D. S. Epidemiology and therapeutic strategies for women with preexisting diabetes in pregnancy: how far have we come? The 2021 Norbert Freinkel Award Lecture. Diabetes Care 45, 2484–2491 (2022).
Google Scholar
Mackin, S. T. et al. Diabetes and pregnancy: national trends over a 15 year period. Diabetologia 61, 1081–1088 (2018).
Google Scholar
Wang, M. C. et al. Trends in prepregnancy obesity and association with adverse pregnancy outcomes in the United States, 2013 to 2018. J. Am. Heart Assoc. 10, e020717 (2021).
Google Scholar
Strauss, A. et al. Obesity in pregnant women: a 20-year analysis of the German experience. Eur. J. Clin. Nutr. 75, 1757–1763 (2021).
Google Scholar
Poston, L. et al. Preconceptional and maternal obesity: epidemiology and health consequences. Lancet Diabetes Endocrinol. 4, 1025–1036 (2016).
Google Scholar
Ananth, C. V. et al. Changes in the prevalence of chronic hypertension in pregnancy, United States, 1970 to 2010. Hypertension 74, 1089–1095 (2019).
Google Scholar
Care of pregnant women. Boston Med. Surg. J. 166:292–293 (1912).
Jesudason, S. & Tong, A. The patient experience of kidney disease and pregnancy. Best. Pract. Res. Clin. Obstet. Gynaecol. 57, 77–88 (2019).
Google Scholar
Ralston, E. R. et al. Exploring biopsychosocial correlates of pregnancy risk and pregnancy intention in women with chronic kidney disease. J. Nephrol. 36, 1361–1372 (2023).
Google Scholar
Pregnancy and renal disease. Lancet. 2:801–802 (1975).
Mc Laughlin, L. et al. Feminizing care pathways: mixed-methods study of reproductive options, decision making, pregnancy, post-natal care and parenting amongst women with kidney disease. J. Adv. Nurs. 79, 3127–3146 (2023).
Google Scholar
Garlanda, C., Bottazzi, B., Bastone, A. & Mantovani, A. Pentraxins at the crossroads between innate immunity, inflammation, matrix deposition, and female fertility. Annu. Rev. Immunol. 23, 337–366 (2005).
Google Scholar
Camaioni A., Klinger F. G., Campagnolo L., Salustri A. The influence of pentraxin 3 on the ovarian function and its impact on fertility. Front. Immunol. 9, 2808 (2018).
Google Scholar
Rojas, R., Clegg, D. J. & Palmer, B. F. Amenorrhea and estrogen disorders in kidney disease. Semin. Nephrol. 41, 126–132 (2021).
Google Scholar
Wiles, K. et al. Anti-Müllerian hormone concentrations in women with chronic kidney disease. Clin. Kidney J. 14, 537–542 (2021).
Google Scholar
Gupta, J. et al. Association between albuminuria, kidney function, and inflammatory biomarker profile in CKD in CRIC. Clin. J. Am. Soc. Nephrol. 7, 1938–1946 (2012).
Google Scholar
Holley, J. L., Schmidt, R. J., Bender, F. H., Dumler, F. & Schiff, M. Gynecologic and reproductive issues in women on dialysis. Am. J. Kidney Dis. 29, 685–690 (1997).
Google Scholar
Hou, S. Pregnancy in chronic renal insufficiency and end-stage renal disease. Am. J. Kidney Dis. 33, 235–252 (1999).
Google Scholar
Hewawasam, E. et al. Factors influencing fertility rates in Australian women receiving kidney replacement therapy: analysis of linked Australia and New Zealand Dialysis and Transplant Registry and perinatal data over 22 years. Nephrol. Dial. Transpl. 37, 1152–1161 (2022).
Google Scholar
Vrijlandt, W. A. L. et al. Prevalence of chronic kidney disease in women of reproductive age and observed birth rates. J. Nephrol. 36, 1341–1347 (2023).
Google Scholar
Uldall, P. R., Kerr, D. N. & Tacchi, D. Sterility and cyclophosphamide. Lancet. 1, 693–694 (1972).
Google Scholar
Gajjar, R., Miller, S. D., Meyers, K. E. & Ginsberg, J. P. Fertility preservation in patients receiving cyclophosphamide therapy for renal disease. Pediatr. Nephrol. 30, 1099–1106 (2015).
Google Scholar
Kidney Disease: Improving Global Outcomes (KDIGO) glomerular diseases work group. KDIGO 2021 clinical practice guideline for the management of glomerular diseases. Kidney Int. 100, S1–S276 (2021).
Dines, V. A., Garovic, V. D., Parashuram, S., Cosio, F. G. & Kattah, A. G. Pregnancy, contraception, and menopause in advanced chronic kidney disease and kidney transplant. Womens Health Rep. 2, 488–496 (2021).
Rytz, C. L. et al. Menstrual abnormalities and reproductive lifespan in females with CKD: a systematic review and meta-analysis. Clin. J. Am. Soc. Nephrol. 17, 1742–1753 (2022).
Google Scholar
Dines, V. A. & Garovic, V. D. Menopause and chronic kidney disease. Nat. Rev. Nephrol. 20, 4–5 (2023).
Google Scholar
Vellanki, K. & Hou, S. Menopause in CKD. Am. J. Kidney Dis. 71, 710–719 (2018).
Google Scholar
Iwase, A. et al. Anti‐Müllerian hormone as a marker of ovarian reserve: what have we learned, and what should we know? Reprod. Med. Biol. 15, 127–136 (2015).
Google Scholar
Seifer, D. B., Baker, V. L. & Leader, B. Age-specific serum anti-Müllerian hormone values for 17,120 women presenting to fertility centers within the United States. Fertil. Steril. 95, 747–750 (2011).
Google Scholar
Şenateş, E. et al. Serum anti-Müllerian hormone levels are lower in reproductive-age women with Crohn’s disease compared to healthy control women. J. Crohns Colitis 7, e29–e34 (2013).
Google Scholar
Cakmak, E., Karakus, S., Demirpence, O. & Coskun, B. D. Ovarian reserve assessment in celiac patients of reproductive age. Med. Sci. Monit. Int. Med. J. Exp. Clin. Res. 24, 1152–1157 (2018).
Google Scholar
Karampatou, A. et al. Premature ovarian senescence and a high miscarriage rate impair fertility in women with HCV. J. Hepatol. (2017).
Aydogan Mathyk, B., Aslan Cetin, B., Bilici, S., Fasse, J. & Avci, P. Evaluation of ovarian reserve in women with psoriasis. Gynecol. Endocrinol. 35, 608–611 (2019).
Google Scholar
Lin, C. et al. The value of anti-Müllerian hormone in the prediction of spontaneous pregnancy: a systematic review and meta-analysis. Front. Endocrinol. 12, 695157 (2021).
Google Scholar
Steiner, A. Z. et al. Association between biomarkers of ovarian reserve and infertility among older women of reproductive age. JAMA 318, 1367–1376 (2017).
Google Scholar
Venturella, R. et al. OvAge: a new methodology to quantify ovarian reserve combining clinical, biochemical and 3D-ultrasonographic parameters. J. Ovarian Res. 8, 21 (2015).
Google Scholar
Ding, T. et al. Assessment and quantification of ovarian reserve on the basis of machine learning models. Front. Endocrinol. 14, 1087429 (2023).
Google Scholar
Shah, W. et al. The molecular mechanism of sex hormones on Sertoli cell development and proliferation. Front. Endocrinol. 12, 648141 (2021).
Google Scholar
Bhattacharya, I. et al. Testosterone augments FSH signaling by upregulating the expression and activity of FSH-Receptor in Pubertal Primate Sertoli cells. Mol. Cell Endocrinol. 482, 70–80 (2019).
Google Scholar
Scarabelli, L., Caviglia, D., Bottazzi, C. & Palmero, S. Prolactin effect on pre-pubertal Sertoli cell proliferation and metabolism. J. Endocrinol. Invest. 26, 718–722 (2003).
Google Scholar
Guillaumot, P., Tabone, E. & Benahmed, M. Sertoli cells as potential targets of prolactin action in the testis. Mol. Cell Endocrinol. 122, 199–206 (1996).
Google Scholar
Petersen, C. & Soder, O. The Sertoli cell — a hormonal target and ‘super’ nurse for germ cells that determines testicular size. Horm. Res. 66, 153–161 (2006).
Google Scholar
Palmer, B. F. Sexual dysfunction in men and women with chronic kidney disease and end-stage kidney disease. Adv. Ren. Replace. Ther. 10, 48–60 (2003).
Google Scholar
Eckersten, D., Giwercman, A. & Christensson, A. Male patients with terminal renal failure exhibit low serum levels of antimüllerian hormone. Asian J. Androl. 17, 149–153 (2015).
Google Scholar
Gill-Sharma, M. K. Prolactin and male fertility: the long and short feedback regulation. Int. J. Endocrinol. 2009, 687259 (2009).
Google Scholar
Romejko, K., Rymarz, A., Sadownik, H. & Niemczyk, S. Testosterone deficiency as one of the major endocrine disorders in chronic kidney disease. Nutrients 14, 3438 (2022).
Google Scholar
Khurana, K. K. et al. Serum testosterone levels and mortality in men with CKD stages 3–4. Am. J. Kidney Dis. 64, 367–374 (2014).
Google Scholar
Fantus, R. J. et al. Serum total testosterone and premature mortality among men in the USA. Eur. Urol. Open. Sci. 29, 89–92 (2021).
Google Scholar
Ros, S. & Carrero, J. J. Endocrine alterations and cardiovascular risk in CKD: is there a link? Nefrol. Engl. Ed. 33, 181–187 (2013).
Guay, A., Seftel, A. D. & Traish, A. Hypogonadism in men with erectile dysfunction may be related to a host of chronic illnesses. Int. J. Impot. Res. 22, 9–19 (2010).
Google Scholar
Bass, A. et al. The impact of nocturnal hemodialysis on sexual function. BMC Nephrol. 13, 67 (2012).
Google Scholar
Van Eps, C. et al. Changes in serum prolactin, sex hormones and thyroid function with alternate nightly nocturnal home haemodialysis. Nephrology 17, 42–47 (2012).
Google Scholar
Kuczera, P., Więcek, A. & Adamczak, M. Impaired fertility in women and men with chronic kidney disease. Adv. Clin. Exp. Med. 31, 187–195 (2022).
Google Scholar
Eckersten, D., Giwercman, A., Pihlsgård, M., Bruun, L. & Christensson, A. Impact of kidney transplantation on reproductive hormone levels in males: a longitudinal study. Nephron 138, 192–201 (2017).
Google Scholar
Zhang, Y. et al. Kidney transplantation improve semen quality in patients with dialysis: a systematic review and meta-analysis. Andrologia 53, e14158 (2021).
Google Scholar
Lehtihet, M. & Hylander, B. Semen quality in men with chronic kidney disease and its correlation with chronic kidney disease stages. Andrologia 47, 1103–1108 (2015).
Google Scholar
Boitrelle, F. et al. The sixth edition of the WHO manual for human semen analysis: a critical review and SWOT analysis. Life 11, 1368 (2021).
Google Scholar
Bonde, J. P. et al. Relation between semen quality and fertility: a population-based study of 430 first-pregnancy planners. Lancet Lond. Engl. 352, 1172–1177 (1998).
Google Scholar
Slama, R. et al. Time to pregnancy and semen parameters: a cross-sectional study among fertile couples from four European cities. Hum. Reprod. Oxf. Engl. 17, 503–515 (2002).
Google Scholar
Björndahl, L. A paradigmatic shift in the care of male factor infertility: how can the recommendations for basic semen examination in the sixth edition of the WHO manual and the ISO 23162:2021 standard help? Reprod. Biomed. Online 45, 731–736 (2022).
Google Scholar
Esteves, S. C. Evolution of the World Health Organization semen analysis manual: where are we? Nat. Rev. Urol. 19, 439–446 (2022).
Google Scholar
Haddock, L. et al. Sperm DNA fragmentation is a novel biomarker for early pregnancy loss. Reprod. Biomed. Online 42, 175–184 (2021).
Google Scholar
Dai, Y. Relationship among traditional semen parameters, sperm DNA fragmentation, and unexplained recurrent miscarriage: a systematic review and meta-analysis. Front. Endocrinol. 12, 802632 (2021).
Google Scholar
Borges, E. et al. Sperm DNA fragmentation is correlated with poor embryo development, lower implantation rate, and higher miscarriage rate in reproductive cycles of non-male factor infertility. Fertil. Steril. 112, 483–490 (2019).
Google Scholar
Homa, S. T. et al. A comparison between two assays for measuring seminal oxidative stress and their relationship with sperm DNA fragmentation and semen parameters. Genes 10, 236 (2019).
Google Scholar
Aitken, R. J. & De Iuliis, G. N. On the possible origins of DNA damage in human spermatozoa. Mol. Hum. Reprod. 16, 3–13 (2010).
Google Scholar
Duni, A., Liakopoulos, V., Roumeliotis, S., Peschos, D. & Dounousi, E. Oxidative stress in the pathogenesis and evolution of chronic kidney disease: untangling Ariadne’s thread. Int. J. Mol. Sci. 20, 3711 (2019).
Google Scholar
Javadneia, A. et al. Sperm DNA damage before and after kidney transplantation. Nephro-Urol. Mon. 11, e86990 (2019).
Colombijn, J. M. et al. Antioxidants for adults with chronic kidney disease. Cochrane Database Syst. Rev. 11, CD008176 (2023).
Google Scholar
de Ligny, W. et al. Antioxidants for male subfertility. Cochrane Database Syst. Rev. 5, CD007411 (2022).
Google Scholar
Pyrgidis, N. et al. Prevalence of erectile dysfunction in patients with end-stage renal disease: a systematic review and meta-analysis. J. Sex. Med. 18, 113–120 (2021).
Google Scholar
Edey, M. M. Male sexual dysfunction and chronic kidney disease. Front. Med. 4, 32 (2017).
Google Scholar
Lotti, F. & Maggi, M. Sexual dysfunction and male infertility. Nat. Rev. Urol. 15, 287–307 (2018).
Google Scholar
Vecchio, M. et al. Interventions for treating sexual dysfunction in patients with chronic kidney disease. Cochrane Database Syst. Rev. 8, CD007747 (2010).
Lundy, S. D. & Vij, S. C. Male infertility in renal failure and transplantation. Transl. Androl. Urol. 8, 173–181 (2019).
Google Scholar
Mondal, S., Sinha Roy, P. P. & Pal, D. K. Sexual well-being and fertility in male renal transplant recipients: a study in a tertiary care centre. Urol. J. 89, 636–640 (2022).
Google Scholar
Tainio, J. et al. Testicular function, semen quality, and fertility in young men after renal transplantation during childhood or adolescence. Transplantation 98, 987–993 (2014).
Google Scholar
Bearak, J. et al. Unintended pregnancy and abortion by income, region, and the legal status of abortion: estimates from a comprehensive model for 1990–2019. Lancet Glob. Health 8, e1152–e1161 (2020).
Google Scholar
Ghazizadeh, S. et al. Unwanted pregnancy among kidney transplant recipients in Iran. Transpl. Proc. 37, 3085–3086 (2005).
Google Scholar
Lessan-Pezeshki, M. et al. Fertility and contraceptive issues after kidney transplantation in women. Transpl. Proc. 36, 1405–1406 (2004).
Google Scholar
Shah, S., Christianson, A. L., Bumb, S. & Verma, P. Contraceptive use among women with kidney transplants in the United States. J. Nephrol. 35, 629–638 (2022).
Google Scholar
Britton, L. Unintended pregnancy: a systematic review of contraception use and counseling in women with cancer. Clin. J. Oncol. Nurs. 21, 189–196 (2017).
Google Scholar
Phillips-Bell, G. S., Sappenfield, W., Robbins, C. L. & Hernandez, L. Chronic diseases and use of contraception among women at risk of unintended pregnancy. J. Womens Health 25, 1262–1269 (2016).
Google Scholar
Harris, M. L. et al. Patterns of contraceptive use among young Australian women with chronic disease: findings from a prospective cohort study. Reprod. Health 19, 111 (2022).
Google Scholar
Baker, R. J., Mark, P. B., Patel, R. K., Stevens, K. K. & Palmer, N. Renal association clinical practice guideline in post-operative care in the kidney transplant recipient. BMC Nephrol. 18, 174 (2017).
Google Scholar
Wiles, K. et al. Clinical practice guideline on pregnancy and renal disease. BMC Nephrol. 20, 401 (2019).
Google Scholar
Brynhildsen, J. Combined hormonal contraceptives: prescribing patterns, compliance, and benefits versus risks. Ther. Adv. Drug. Saf. 5, 201–213 (2014).
Google Scholar
Attini, R. et al. Contraception in chronic kidney disease: a best practice position statement by the Kidney and Pregnancy Group of the Italian Society of Nephrology. J. Nephrol. 33, 1343–1359 (2020).
Google Scholar
Browne, H., Manipalviratn, S. & Armstrong, A. Using an intrauterine device in immunocompromised women. Obstet. Gynecol. 112, 667–669 (2008).
Google Scholar
Balbach, M. et al. On-demand male contraception via acute inhibition of soluble adenylyl cyclase. Nat. Commun. 14, 637 (2023).
Google Scholar
Koilpillai, J. N., Nunan, E., Butler, L., Pinaffi, F. & Butcher, J. T. Reversible contraception in males: an obtainable target? Biology 13, 291 (2024).
Google Scholar
Thirumalai, A. & Page, S. T. Recent developments in male contraception. Drugs 79, 11–20 (2019).
Google Scholar
Trussell, J. Contraceptive failure in the United States. Contraception 83, 397–404 (2011).
Google Scholar
Abbe, C. R., Page, S. T. & Thirumalai, A. Male contraception. Yale J. Biol. Med. 93, 603–613 (2020).
Google Scholar
Berer, M. Abortion law and policy around the world. Health Hum. Rights 19, 13–27 (2017).
Google Scholar
Qi, A. & Hladunewich, M. A. Nephrology and women’s health post-Roe v. Wade: we must do better. Nat. Rev. Nephrol. 18, 741–742 (2022).
Google Scholar
Rizzolo, K., Faucett, A. & Kendrick, J. Implications of antiabortion laws on patients with kidney disease in pregnancy. Clin. J. Am. Soc. Nephrol. 18, 276–278 (2023).
Google Scholar
Robinson, G. E. et al. The mental and physical health impacts of overturning Roe v Wade. J. Nerv. Ment. Dis. 210, 891–893 (2022).
Google Scholar
Piccoli, G. B. et al. The children of dialysis: live-born babies from on-dialysis mothers in Italy — an epidemiological perspective comparing dialysis, kidney transplantation and the overall population. Nephrol. Dial. Transpl. 29, 1578–1586 (2014).
Google Scholar
Ahmed, S. B., Vitek, W. S. & Holley, J. L. Fertility, contraception, and novel reproductive technologies in chronic kidney disease. Semin. Nephrol. 37, 327–336 (2017).
Google Scholar
Tangren, J., Nadel, M. & Hladunewich, M. A. Pregnancy and end-stage renal disease. Blood Purif. 45, 194–200 (2018).
Google Scholar
Horsey K. The future of surrogacy: a review of current global trends and national landscapes. Reprod Biomed Online. 48, 103764.
Madej, A., Mazanowska, N., Cyganek, A., Pazik, J. & Pietrzak, B. Neonatal and maternal outcomes among women with glomerulonephritis. Am. J. Nephrol. 51, 534–541 (2020).
Google Scholar
Sifontis, N. M. et al. Pregnancy outcomes in solid organ transplant recipients with exposure to mycophenolate mofetil or sirolimus. Transplantation 82, 1698–1702 (2006).
Google Scholar
Drugs and Lactation Database (LactMed). National Center for Biotechnology Information (2006).
Flint, J. et al. BSR and BHPR guideline on prescribing drugs in pregnancy and breastfeeding-Part I: standard and biologic disease modifying anti-rheumatic drugs and corticosteroids. Rheumatol. Oxf. Engl. 55, 1693–1697 (2016).
Google Scholar
Wallace, D. J., Gudsoorkar, V. S., Weisman, M. H. & Venuturupalli, S. R. New insights into mechanisms of therapeutic effects of antimalarial agents in SLE. Nat. Rev. Rheumatol. 8, 522–533 (2012).
Google Scholar
Zemlickis, D. et al. Fetal outcome after in utero exposure to cancer chemotherapy. Arch. Intern. Med. 152, 573–576 (1992).
Google Scholar
Boulay, H. et al. Maternal, foetal and child consequences of immunosuppressive drugs during pregnancy in women with organ transplant: a review. Clin. Kidney J. 14, 1871–1878 (2021).
Google Scholar
Perrotta, K., Kiernan, E., Bandoli, G., Manaster, R. & Chambers, C. Pregnancy outcomes following maternal treatment with rituximab prior to or during pregnancy: a case series. Rheumatol. Adv. Pract. 5, rkaa074 (2021).
Google Scholar
Kao, J. H. et al. Pregnancy outcomes in patients treated with belimumab: report from real-world experience. Semin. Arthritis Rheum. 51, 963–968 (2021).
Google Scholar
FDA. Rapamune. (sirolimus) drug information sheet. https://www.accessdata.fda.gov/drugsatfda_docs/label/2003/021083s006lbl.pdf.
Ponticelli, C. & Moroni, G. Fetal toxicity of immunosuppressive drugs in pregnancy. J. Clin. Med. 7, 552 (2018).
Google Scholar
Tshering, S., Dorji, N., Youden, S. & Wangchuk, D. Maternal sirolimus therapy and fetal growth restriction. Arch. Clin. Cases 8, 19–24 (2021).
Google Scholar
Lip, G. Y., Churchill, D., Beevers, M., Auckett, A. & Beevers, D. G. Angiotensin-converting-enzyme inhibitors in early pregnancy. Lancet. 350, 1446–1447 (1997).
Google Scholar
Centers for Disease Control and Prevention (CDC). Postmarketing surveillance for angiotensin-converting enzyme inhibitor use during the first trimester of pregnancy — United States, Canada, and Israel, 1987–1995. MMWR Morb. Mortal. Wkly. Rep. 46, 240–242 (1997).
Bar, J., Hod, M. & Merlob, P. Angiotensin converting enzyme inhibitors use in the first trimester of pregnancy. Int. J. Risk Saf. Med. 10, 23–26 (1997).
Google Scholar
Steffensen, F. H., Nielsen, G. L., Sørensen, H. T., Olesen, C. & Olsen, J. Pregnancy outcome with ACE-inhibitor use in early pregnancy. Lancet Lond. Engl. 351, 596 (1998).
Google Scholar
Li, D. K., Yang, C., Andrade, S., Tavares, V. & Ferber, J. R. Maternal exposure to angiotensin converting enzyme inhibitors in the first trimester and risk of malformations in offspring: a retrospective cohort study. BMJ 343, d5931 (2011).
Google Scholar
Hünseler, C. et al. Angiotensin II receptor blocker induced fetopathy: 7 cases. Klin. Pädiatr. 223, 10–14 (2011).
Google Scholar
Mosley, J. F., Smith, L., Everton, E. & Fellner, C. Sodium-glucose linked transporter 2 (SGLT2) inhibitors in the management of type-2 diabetes: a drug class overview. Pharm. Ther. 40, 451–462 (2015).
Tangren, J. et al. Pre-Pregnancy eGFR and the risk of adverse maternal and fetal outcomes: a population-based study. J. Am. Soc. Nephrol. 34, 656–667 (2023).
Google Scholar
Bramham, K. Diabetic nephropathy and pregnancy. Semin. Nephrol. 37, 362–369 (2017).
Google Scholar
Al Khalaf, S. et al. Impact of chronic hypertension and antihypertensive treatment on adverse perinatal outcomes: systematic review and meta-analysis. J. Am. Heart Assoc. 10, e018494 (2021).
Google Scholar
Wiles, K. et al. The impact of chronic kidney disease stages 3–5 on pregnancy outcomes. Nephrol. Dial. Transpl. 36, 2008–2017 (2021).
Google Scholar
Piccoli, G. B. et al. Risk of adverse pregnancy outcomes in women with CKD. J. Am. Soc. Nephrol. 26, 2011–2022 (2015).
Google Scholar
EMA recommends additional measures to prevent use of mycophenolate in pregnancy. 2015. Available: (2015).
Damkier, P., Passier, A., Bo Petersen, L., Havnen, G. & Thestrup Pedersen, A. J. Changing of the guards: EMA warning on paternal use of mycophenolate mofetil: an unnecessary and insufficiently substantiated precaution. Birth Defects Res. A Clin. Mol. Teratol. 106, 860–861 (2016).
Google Scholar
Midtvedt, K., Bergan, S., Reisæter, A. V., Vikse, B. E. & Åsberg, A. Exposure to mycophenolate and fatherhood. Transplantation 101, e214–e217 (2017).
Google Scholar
Le, H. L. et al. Usage of tacrolimus and mycophenolic acid during conception, pregnancy, and lactation, and its implications for therapeutic drug monitoring: a systematic critical review. Ther. Drug. Monit. 42, 518–531 (2020).
Google Scholar
Boyer, A. et al. Paternity in male kidney transplant recipients: a French national survey, the PATeRNAL study. BMC Nephrol. 21, 483 (2020).
Google Scholar
Jesudason, S. et al. Fatherhood and kidney replacement therapy: analysis of the Australian and New Zealand dialysis and transplant (ANZDATA) registry. Am. J. Kidney Dis. 76, 444–446 (2020).
Google Scholar
Jones, D. C. & Hayslett, J. P. Outcome of pregnancy in women with moderate or severe renal insufficiency. N. Engl. J. Med. 335, 226–232 (1996).
Google Scholar
Bramham, K. et al. Pregnancy outcome in women with chronic kidney disease: a prospective cohort study. Reprod. Sci. 18, 623–630 (2011).
Google Scholar
Bramham, K. et al. Diagnostic and predictive biomarkers for pre-eclampsia in patients with established hypertension and chronic kidney disease. Kidney Int. 89, 874–885 (2016).
Google Scholar
He, Y. et al. The pregnancy outcomes in patients with stage 3–4 chronic kidney disease and the effects of pregnancy in the long-term kidney function. J. Nephrol. 31, 953–960 (2018).
Google Scholar
Reynolds, M. L. et al. Pregnancy history and kidney disease progression among women enrolled in cure glomerulonephropathy. Kidney Int. Rep. 8, 805–817 (2023).
Google Scholar
Major, R. W. et al. The Kidney Failure Risk Equation for prediction of end stage renal disease in UK primary care: an external validation and clinical impact projection cohort study. PLoS Med. 16, e1002955 (2019).
Google Scholar
Ralston, E. et al. POS-234 pregnancy-associated progression of chronic kidney disease: development of a clinical predictive tool. Kidney Int. Rep. 6, S99 (2021).
Google Scholar
Ralston, E. et al. Pregnancy-associated progression of chronic kidney disease: a study protocol for the development and validation of a clinical predictive tool (PREDICT). J. Nephrol. 3, 773–776 (2024).
Smith, P. et al. ORCHARD: a model for conducting pragmatic randomised trials in pregnancy. J. Nephrol. 37, 1411—1413 (2024).
Webb, A. J. et al. Acute blood pressure lowering, vasoprotective, and antiplatelet properties of dietary nitrate via bioconversion to nitrite. Hypertension 51, 784–790 (2008).
Google Scholar
Kemmner, S. et al. Dietary nitrate load lowers blood pressure and renal resistive index in patients with chronic kidney disease: a pilot study. Nitric Oxide Biol. Chem. 64, 7–15 (2017).
Google Scholar
Ormesher, L. et al. Effects of dietary nitrate supplementation, from beetroot juice, on blood pressure in hypertensive pregnant women: a randomised, double-blind, placebo-controlled feasibility trial. Nitric Oxide 80, 37–44 (2018).
Google Scholar
ORCHARD: Study to prevent progression of kidney disease in pregnancy. https://www.isrctn.com/ISRCTN91211980.
Cabiddu, G. et al. A best practice position statement on pregnancy in chronic kidney disease: the Italian Study Group on Kidney and Pregnancy. J. Nephrol. 29, 277–303 (2016).
Google Scholar
Jong, M. F. C., de, Hamersvelt, H. W., van, Empel, I. W. H., van, Nijkamp, E. J. W. & Lely, A. T. Summary of the Dutch practice guideline on pregnancy wish and pregnancy in CKD. Kidney Int. Rep. 7, 2575–2588 (2022).
Google Scholar
Henderson, J. T. et al. Low-dose aspirin for prevention of morbidity and mortality from preeclampsia: a systematic evidence review for the U.S. Preventive Services Task Force. Ann. Intern. Med. 160, 695–703 (2014).
Google Scholar
Rolnik, D. L. et al. Aspirin versus placebo in pregnancies at high risk for preterm preeclampsia. N. Engl. J. Med. 377, 613–622 (2017).
Google Scholar
Gordon, C. et al. The British Society for Rheumatology guideline for the management of systemic lupus erythematosus in adults. Rheumatol. Oxf. Engl. 57, e1–e45 (2018).
Google Scholar
Izmirly, P. M. et al. Evaluation of the risk of anti-SSA/Ro-SSB/La antibody-associated cardiac manifestations of neonatal lupus in fetuses of mothers with systemic lupus erythematosus exposed to hydroxychloroquine. Ann. Rheum. Dis. 69, 1827–1830 (2010).
Google Scholar
Barsalou, J. et al. Prenatal exposure to antimalarials decreases the risk of cardiac but not non-cardiac neonatal lupus: a single-centre cohort study. Rheumatol. Oxf. Engl. 56, 1552–1559 (2017).
Google Scholar
Derdulska, J. M. et al. Neonatal lupus erythematosus — practical guidelines. J. Perinat. Med. 49, 529–538 (2021).
Google Scholar
Ahn, H. K. et al. Exposure to amlodipine in the first trimester of pregnancy and during breastfeeding. Hypertens. Pregnancy 26, 179–187 (2007).
Google Scholar
Mito, A. et al. Safety of amlodipine in early pregnancy. J. Am. Heart Assoc. 8, e012093 (2019).
Google Scholar
Ishikawa, T. et al. Risk of major congenital malformations associated with first-trimester antihypertensives, including amlodipine and methyldopa: a large claims database study 2010–2019. Pregnancy Hypertens. 31, 73–83 (2023).
Google Scholar
Benachi, A. et al. Down syndrome maternal serum screening in patients with renal disease. Am. J. Obstet. Gynecol. 203, 60.e1–e4 (2010).
Google Scholar
Valentin, M. et al. First-trimester combined screening for trisomy 21 in women with renal disease. Prenat. Diagn. 35, 244–248 (2015).
Google Scholar
Qureshi, H. et al. BCSH guideline for the use of anti-D immunoglobulin for the prevention of haemolytic disease of the fetus and newborn. Transfus. Med. Oxf. Engl. 24, 8–20 (2014).
Google Scholar
National Institute for Health and Care Excellence. Antenatal Care [NICE Guideline No. 201] (2021).
Nevis, I. F. et al. Pregnancy outcomes in women with chronic kidney disease: a systematic review. Clin. J. Am. Soc. Nephrol. 6, 2587–2598 (2011).
Google Scholar
Zhang, J. J. et al. A systematic review and meta-analysis of outcomes of pregnancy in CKD and CKD outcomes in pregnancy. Clin. J. Am. Soc. Nephrol. 10, 1964–1978 (2015).
Google Scholar
NICE guideline. Hypertension in pregnancy: diagnosis and management. Am. J. Obstet. Gynecol. 77, S1–S22 (2019).
Oliverio, A. L. & Hladunewich, M. A. End stage kidney disease and dialysis in pregnancy. Adv. Chronic Kidney Dis. 27, 477–485 (2020).
Google Scholar
Hou, S. H. Frequency and outcome of pregnancy in women on dialysis. Am. J. Kidney Dis. 23, 60–63 (1994).
Google Scholar
Bagon, J. A. et al. Pregnancy and dialysis. Am. J. Kidney Dis. 31, 756 (1998).
Google Scholar
Basok, E. K. et al. Assessment of female sexual function and quality of life in predialysis, peritoneal dialysis, hemodialysis, and renal transplant patients. Int. Urol. Nephrol. 41, 473–481 (2009).
Google Scholar
Matuszkiewicz-Rowinska, J. et al. Endometrial morphology and pituitary-gonadal axis dysfunction in women of reproductive age undergoing chronic haemodialysis — a multicentre study. Nephrol. Dial. Transpl. 19, 2074–2077 (2004).
Google Scholar
Hosfield, E. M., Rabban, J. T., Chen, L. M. & Zaloudek, C. J. Squamous metaplasia of the ovarian surface epithelium and subsurface fibrosis: distinctive pathologic findings in the ovaries and fallopian tubes of patients on peritoneal dialysis. Int. J. Gynecol. Pathol. 27, 465–474 (2008).
Google Scholar
Confortini, P. et al. Full term successful pregnancy and successful delivery in a patient on chronic haemodialysis. Proc. Eur. Dial. Transpl. Assoc. 8, 74–80 (1971).
Piccoli, G. B. et al. Pregnancy in dialysis patients in the new millennium: a systematic review and meta-regression analysis correlating dialysis schedules and pregnancy outcomes. Nephrol. Dial. Transplant. 31, 1915–1934 (2016).
Google Scholar
Baouche, H. et al. Pregnancy in women on chronic dialysis in the last decade (2010–2020): a systematic review. Clin. Kidney J. 16, 138–150 (2023).
Google Scholar
Hladunewich, M. A. et al. Intensive hemodialysis associates with improved pregnancy outcomes: a Canadian and United States cohort comparison. J. Am. Soc. Nephrol. 25, 1103–1109 (2014).
Google Scholar
Luders, C., Titan, S. M., Kahhale, S., Francisco, R. P. & Zugaib, M. Risk factors for adverse fetal outcome in hemodialysis pregnant women. Kidney Int. Rep. 3, 1077–1088 (2018).
Google Scholar
Bramham, K. et al. Pregnancy in renal transplant recipients: a UK national cohort study. Clin. J. Am. Soc. Nephrol. 8, 290–298 (2013).
Google Scholar
Chappell, L. C., Cluver, C. A., Kingdom, J. & Tong, S. Pre-eclampsia. Lancet 398, 341–354 (2021).
Google Scholar
Tan, M. Y. et al. Screening for pre-eclampsia by maternal factors and biomarkers at 11–13 weeks’ gestation. Ultrasound Obstet. Gynecol. 52, 186–195 (2018).
Google Scholar
Chappell, L. C. et al. Diagnostic accuracy of placental growth factor in women with suspected preeclampsia: a prospective multicenter study. Circulation 128, 2121–2131 (2013).
Google Scholar
Duhig, K. E. et al. Placental growth factor testing to assess women with suspected pre-eclampsia: a multicentre, pragmatic, stepped-wedge cluster-randomised controlled trial. Lancet 393, 1807–1818 (2019).
Google Scholar
Cerdeira, A. S. et al. Randomized interventional study on prediction of preeclampsia/eclampsia in women with suspected preeclampsia: INSPIRE. Hypertension 74, 983–990 (2019).
Google Scholar
Wiles, K. et al. Placental and endothelial biomarkers for the prediction of superimposed pre-eclampsia in chronic kidney disease. Pregnancy Hypertens. 24, 58–64 (2021).
Google Scholar
Gupta, M., Feinberg, B. B. & Burwick, R. M. Thrombotic microangiopathies of pregnancy: differential diagnosis. Pregnancy Hypertens. 12, 29–34 (2018).
Google Scholar
Moroni, G., Calatroni, M., Donato, B. & Ponticelli, C. Kidney biopsy in pregnant women with glomerular diseases: focus on lupus nephritis. J. Clin. Med. 12, 1834 (2023).
Google Scholar
Harel, Z. et al. Serum creatinine levels before, during, and after pregnancy. JAMA 321, 205–207 (2019).
Google Scholar
Machado S et al. Acute kidney injury in pregnancy: a clinical challenge. J. Nephrol. 25, 19–30 (2012).
Google Scholar
Wiles, K. et al. Serum creatinine in pregnancy: a systematic review. Kidney Int. Rep. 4, 408–419 (2018).
Google Scholar
Gama, R. M. et al. Acute kidney injury e-alerts in pregnancy: rates, recognition and recovery. Nephrol. Dial. Transpl. 36, 1023–1030 (2021).
Google Scholar
Conti-Ramsden, F. I. et al. Pregnancy-related acute kidney injury in preeclampsia: risk factors and renal outcomes. Hypertension 74, 1144–1151 (2019).
Google Scholar
Noble, R. A., Lucas, B. J. & Selby, N. M. Long-term outcomes in patients with acute kidney injury. Clin. J. Am. Soc. Nephrol. 15, 423–429 (2020).
Google Scholar
Ciciu, E., Paṣatu-Cornea, A. M., Petcu, L. C. & Tuţă, L. A. Early diagnosis and management of maternal ureterohydronephrosis during pregnancy. Exp. Ther. Med. 23, 27 (2022).
Google Scholar
Denstedt, J. D. & Razvi, H. Management of urinary calculi during pregnancy. J. Urol. 148, 1072–1074 (1992).
Google Scholar
Lee, J. Y. et al. Canadian Urological Association guideline: management of ureteral calculi — full-text. Can. Urol. Assoc. J. 15, E676–E690 (2021).
Google Scholar
Clark, K. et al. WCN24-1183 Assessing kidney function in pregnancy: gestation specific centile reference ranges for serum creatinine, urea, cystatin c and beta-2-microglobulin. Kidney Int. Rep. 9, S435–S436 (2024).
Google Scholar
Chu, C. D. et al. CKD awareness among US adults by future risk of kidney failure. Am. J. Kidney Dis. 76, 174–183 (2020).
Google Scholar
Piccoli, G. B. et al. Adding creatinine to routine pregnancy tests: a decision tree for calculating the cost of identifying patients with CKD in pregnancy. Nephrol. Dial. Transpl. 38, 148–157 (2023).
Google Scholar
Crump, C., Sundquist, J. & Sundquist, K. Preterm or early term birth and risk of autism. Pediatrics 148, e2020032300 (2021).
Google Scholar
Wang, C., Geng, H., Liu, W. & Zhang, G. Prenatal, perinatal, and postnatal factors associated with autism: a meta-analysis. Medicine 96, e6696 (2017).
Google Scholar
Wiles, K. S., Nelson-Piercy, C. & Bramham, K. Reproductive health and pregnancy in women with chronic kidney disease. Nat. Rev. Nephrol. 14, 165–184 (2018).
Google Scholar
Ramakrishnan, A., Lee, L. J., Mitchell, L. E. & Agopian, A. J. Maternal hypertension during pregnancy and the risk of congenital heart defects in offspring: a systematic review and meta-analysis. Pediatr. Cardiol. 36, 1442 (2015).
Google Scholar
van Gelder, M. M. H. J. et al. Maternal hypertensive disorders, antihypertensive medication use, and the risk of birth defects: a case-control study. BJOG 122, 1002–1009 (2015).
Google Scholar
Magee, L. A. et al. Less-tight versus tight control of hypertension in pregnancy. N. Engl. J. Med. 372, 407–417 (2015).
Google Scholar
At, T. et al. Treatment for mild chronic hypertension during pregnancy. N. Engl. J. Med. 386, 1781–1792.
Luyckx, V. A. & Chevalier, R. L. Impact of early life development on later onset chronic kidney disease and hypertension and the role of evolutionary trade-offs. Exp. Physiol. 107, 410–414 (2022).
Google Scholar
Hughson, M., Farris, A. B., Douglas-Denton, R., Hoy, W. E. & Bertram, J. F. Glomerular number and size in autopsy kidneys: the relationship to birth weight. Kidney Int. 63, 2113–2122 (2003).
Google Scholar
Sutherland, M. R. & Black, M. J. The impact of intrauterine growth restriction and prematurity on nephron endowment. Nat. Rev. Nephrol. 19, 218–228 (2023).
Google Scholar
Stonestreet, B. S., Hansen, N. B., Laptook, A. R. & Oh, W. Glucocorticoid accelerates renal functional maturation in fetal lambs. Early Hum. Dev. 8, 331–341 (1983).
Google Scholar
Leeson, C. P. M., Kattenhorn, M., Morley, R., Lucas, A. & Deanfield, J. E. Impact of low birth weight and cardiovascular risk factors on endothelial function in early adult life. Circulation 103, 1264–1268 (2001).
Google Scholar
Cwiek, A. et al. Premature differentiation of nephron progenitor cell and dysregulation of gene pathways critical to kidney development in a model of preterm birth. Sci. Rep. 11, 21667 (2021).
Google Scholar
Warrington, N. M. et al. Maternal and fetal genetic effects on birth weight and their relevance to cardio-metabolic risk factors. Nat. Genet. 51, 804–814 (2019).
Google Scholar
Grillo, M. A., Mariani, G. & Ferraris, J. R. Prematurity and low birth weight in neonates as a risk factor for obesity, hypertension, and chronic kidney disease in pediatric and adult age. Front. Med. 8, 769734 (2021).
Google Scholar
Kelsey, T. W. et al. Ovarian volume throughout life: a validated normative model. PLoS ONE 8, e71465 (2013).
Google Scholar
Sharpe, R. M., McKinnell, C., Kivlin, C. & Fisher, J. S. Proliferation and functional maturation of Sertoli cells, and their relevance to disorders of testis function in adulthood. Reprod. Camb. Engl. 125, 769–784 (2003).
Google Scholar
Ratcliffe, J. M., Gladen, B. C., Wilcox, A. J. & Herbst, A. L. Does early exposure to maternal smoking affect future fertility in adult males? Reprod. Toxicol. Elmsford N. 6, 297–307 (1992).
Google Scholar
Jensen, T. K. et al. Adult and prenatal exposures to tobacco smoke as risk indicators of fertility among 430 Danish couples. Am. J. Epidemiol. 148, 992–997 (1998).
Google Scholar
Storgaard, L. et al. Does smoking during pregnancy affect sons’ sperm counts? Epidemiol. Camb. Mass. 14, 278–286 (2003).
Google Scholar
Jensen, T. K. et al. Association of in utero exposure to maternal smoking with reduced semen quality and testis size in adulthood: a cross-sectional study of 1,770 young men from the general population in five European countries. Am. J. Epidemiol. 159, 49–58 (2004).
Google Scholar
Juul, A. et al. Possible fetal determinants of male infertility. Nat. Rev. Endocrinol. 10, 553–562 (2014).
Google Scholar
Hildebrandt, F. Genetic kidney diseases. Lancet 375, 1287–1295 (2010).
Google Scholar
Torra, R., Furlano, M., Ortiz, A. & Ars, E. Genetic kidney diseases as an underrecognized cause of chronic kidney disease: the key role of international registry reports. Clin. Kidney J. 14, 1879–1885 (2021).
Google Scholar
Connaughton, D. M. et al. The Irish kidney gene project — prevalence of family history in patients with kidney disease in Ireland. Nephron 130, 293–301 (2015).
Google Scholar
Thakoordeen-Reddy, S. et al. Maternal variants within the apolipoprotein L1 gene are associated with preeclampsia in a South African cohort of African ancestry. Eur. J. Obstet. Gynecol. Reprod. Biol. 246, 129–133 (2020).
Google Scholar
Reidy, K. J. et al. Fetal — not maternal — APOL1 genotype associated with risk for preeclampsia in those with African ancestry. Am. J. Hum. Genet. 103, 367–376 (2018).
Google Scholar
Sampson, M. G. et al. Integrative genomics identifies novel associations with APOL1 risk genotypes in Black Neptune subjects. J. Am. Soc. Nephrol. 27, 814–823 (2016).
Google Scholar
Moxey-Mims, M. Kidney disease in African American children: biological and nonbiological disparities. Am. J. Kidney Dis. 72, S17–S21 (2018).
Google Scholar
Coscia, L. A. et al. Update on the teratogenicity of maternal mycophenolate mofetil. J. Pediatr. Genet. 4, 42–55 (2015).
Google Scholar
Pham-Huy, A. et al. From mother to baby: antenatal exposure to monoclonal antibody biologics. Expert. Rev. Clin. Immunol. 15, 221–229 (2019).
Google Scholar
Committee on Infectious Diseases AA of P, Kimberlin, D. W., Barnett, E. D., Lynfield, R., Sawyer, M. H. (eds). Immunization in Special Clinical Circumstances. In: Red Book: 2021–2024 Report of the Committee on Infectious Diseases [Internet]. American Academy of Pediatrics, (2021) [cited 2024 Oct 22]. p. 0. Available from: https://doi.org/10.1542/9781610025782.
Hallstensen, R. F. et al. Eculizumab treatment during pregnancy does not affect the complement system activity of the newborn. Immunobiology 220, 452–459 (2015).
Google Scholar
Kramer, M. S. & Kakuma, R. Optimal duration of exclusive breastfeeding. Cochrane Database Syst. Rev. 2012, CD003517 (2012).
Google Scholar
Kramer M. S. & Kakuma R. in Protecting Infants through Human Milk. (eds Pickering L. K., Morrow A. L., Ruiz-Palacios G. M. & Schanler R.J.) Advances in Experimental Medicine and Biology. 63–77 (Springer, 2004).
Stuebe, A. M., Rich-Edwards, J. W., Willett, W. C., Manson, J. E. & Michels, K. B. Duration of lactation and incidence of type 2 diabetes. JAMA 294, 2601–2610 (2005).
Google Scholar
Rød, B. E., Torkildsen, Ø., Myhr, K.-M., Bø, L. & Wergeland, S. Safety of breast feeding during rituximab treatment in multiple sclerosis. J. Neurol. Neurosurg. Psychiatry 94, 38 (2023).
Google Scholar
Stefanovic, V. The extended use of eculizumab in pregnancy and complement activation−associated diseases affecting maternal, fetal and neonatal kidneys — the future is now? J. Clin. Med. 8, 407 (2019).
Google Scholar
APILAM. [cited 2024 May 30]. http://e-lactancia.org/privacidad/.
Eisenberg, M. L., Li, S., Cullen, M. R. & Baker, L. C. Increased risk of incident chronic medical conditions in infertile men: analysis of United States claims data. Fertil. Steril. 105, 629–636 (2016).
Google Scholar
Kitlinski, M., Giwercman, A., Christensson, A., Nilsson, P. M. & Elenkov, A. Prevalence of impaired renal function among childless men as compared to fathers: a population-based study. Sci. Rep. 14, 7720 (2024).
Google Scholar
Imbasciati, E. et al. Pregnancy in CKD stages 3 to 5: fetal and maternal outcomes. Am. J. Kidney Dis. 49, 753–762 (2007).
Google Scholar
Gouveia, I. F., Silva, J. R., Santos, C. & Carvalho, C. Maternal and fetal outcomes of pregnancy in chronic kidney disease: diagnostic challenges, surveillance and treatment throughout the spectrum of kidney disease. J. Bras. Nefrol. 43, 88–102 (2021).
Google Scholar
Bramham, K. Pregnancy in renal transplant recipients and donors. Semin. Nephrol. 37, 370–377 (2017).
Google Scholar
Banerjee, I. et al. Health outcomes of children born to mothers with chronic kidney disease: a pilot study. Pediatr. Rep. 2, 22–25 (2010).
Google Scholar
Abou-Jaoude, P. et al. What about the renal function during childhood of children born from dialysed mothers? Nephrol. Dial. Transpl. 27, 2365–2369 (2012).
Google Scholar
Blowey, D. L. & Warady, B. A. Outcome of infants born to women with chronic kidney disease. Adv. Chronic Kidney Dis. 14, 199–205 (2007).
Google Scholar
Tong, A., Brown, M. A., Winkelmayer, W. C., Craig, J. C. & Jesudason, S. Perspectives on pregnancy in women with CKD: a semistructured interview study. Am. J. Kidney Dis. 66, 951–961 (2015).
Google Scholar
Ralston, E. R., Smith, P., Chilcot, J., Silverio, S. A. & Bramham, K. Perceptions of risk in pregnancy with chronic disease: a systematic review and thematic synthesis. PLoS ONE 16, e0254956 (2021).
Google Scholar
Scherzer, A. L., Chhagan, M., Kauchali, S. & Susser, E. Global perspective on early diagnosis and intervention for children with developmental delays and disabilities. Dev. Med. Child. Neurol. 54, 1079–1084 (2012).
Google Scholar
Bateman, B. T. et al. Late pregnancy β blocker exposure and risks of neonatal hypoglycemia and bradycardia. Pediatrics 138, e20160731 (2016).
Google Scholar
Morgan, J. L. et al. Pharmacokinetics of amlodipine besylate at delivery and during lactation. Pregnancy Hypertens. 11, 77–80 (2018).
Google Scholar
Xie, R. H. et al. Beta-blockers increase the risk of being born small for gestational age or of being institutionalised during infancy. BJOG 121, 1090–1096 (2014).
Google Scholar
Magee L. A., Duley L. Oral beta-blockers for mild to moderate hypertension during pregnancy. Cochrane Database Syst. Rev. 2003, CD002863 (2000).
Google Scholar
Nice, F. J. & Luo, A. C. Medications and breast-feeding: current concepts. J. Am. Pharm. Assoc. 52, 86–94 (2012).
Google Scholar
National Collaborating Centre for Women’s and Children’s Health (UK). Hypertension in Pregnancy: The Management of Hypertensive Disorders During Pregnancy (RCOG Press, 2010).
Ornoy, A. Pharmacological treatment of attention deficit hyperactivity disorder during pregnancy and lactation. Pharm. Res. 35, 46 (2018).
Google Scholar
Schreiber, K. et al. British Society for Rheumatology guideline on prescribing drugs in pregnancy and breastfeeding: comorbidity medications used in rheumatology practice. Rheumatology 62, e89–e104 (2023).
Google Scholar
Sau, A. et al. Azathioprine and breastfeeding: is it safe? BJOG 114, 498–501 (2007).
Google Scholar
Bramham, K., Chusney, G., Lee, J., Lightstone, L. & Nelson-Piercy, C. Breastfeeding and tacrolimus: serial monitoring in breast-fed and bottle-fed infants. Clin. J. Am. Soc. Nephrol. 8, 563 (2013).
Google Scholar
Muller, D. R. P. et al. Effects of GLP-1 agonists and SGLT2 inhibitors during pregnancy and lactation on offspring outcomes: a systematic review of the evidence. Front. Endocrinol. 14 (2023).
World Health Organization. Breastfeeding and maternal medication: recommendations for drugs in the eleventh WHO model list of essential drugs. (2002).
Clark, S. L., Porter, T. F. & West, F. G. Coumarin derivatives and breast-feeding. Obstet. Gynecol. 95, 938–940 (2000).
Google Scholar
link
